The new weight loss pill Belviq (lorcaserin hydrochloride), made by Arena Pharmaceutical's business has been recently approved by the Fda. This is the first drug for long-term weight loss that has been cleared by the Food and Drug administration in 13 years. Belviq works by activating the serotonin 2C receptor in the brain which could help you eat less by feeling full longer after small meals. When used with a mixture of a balanced diet and exercise, this prescribe helps individuals lose about 5% or more of their beginning weight.
According to Janet Woodcock, director of Fda's town for Drug estimate and Research, "Obesity threatens the wide well-being of patients and is a major collective health concern. The approval of this drug, used responsibly in mixture with a wholesome diet and lifestyle, provides a treatment choice for Americans who are obese" or overweight patients who have one other weight-related health such as high blood pressure, type-2 diabetes or high cholesterol.
New Weight Loss Pill Is stylish by Fda
Adults who include a body mass index (Bmi) of 27 or higher (overweight) are approved for this drug which should be ready in the first quarter of 2013. This is also for adults who are obese with a Bmi of 30 or higher.
Approximately 36 percent of adults in America are obese, which is approximately 30 more pounds over a wholesome weight. Those extra pounds increase the risk of heart disease, type-2 diabetes, stroke, many other types of cancer, sleep apnea and other debilitating and chronic diseases. There are about 42 percent of adults who are projected to be obese by the year 2030 if something isn't done to stop the trend.
There were three randomized, placebo-controlled tests that contained approximately 8,000 overweight and obese patients, with and without type-2 diabetes, treated for 52 to 104 weeks. These trials were used to rate the efficacy and safety of Belviq. The results show that individuals who took Belviq for at least 12 months had an median weight loss of 3% to 3.7%.
New Weight Loss Pill Is stylish by Fda [/html]
No comments:
Post a Comment